Gregory Matz Net Worth

The estimated Net Worth of Gregory W Matz is at least $107 mil dollars as of 15 August 2023. Mr. Matz owns over 2,500 units of Dare Bioscience Inc stock worth over $107,352 and over the last 13 years he sold DARE stock worth over $0. In addition, he makes $0 as Independent Director at Dare Bioscience Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Matz DARE stock SEC Form 4 insiders trading

Gregory has made over 10 trades of the Dare Bioscience Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 2,500 units of DARE stock worth $4,425 on 15 August 2023.

The largest trade he's ever made was exercising 10,936 units of Dare Bioscience Inc stock on 13 June 2016 worth over $857,929. On average, Gregory trades about 2,249 units every 137 days since 2012. As of 15 August 2023 he still owns at least 32,930 units of Dare Bioscience Inc stock.

You can see the complete history of Mr. Matz stock trades at the bottom of the page.

Gregory Matz biography

Gregory W. Matz is Independent Director of the company. Until he retired in November 2016, Mr. Matz served as the Senior Vice President, Chief Risk Officer and Chief Financial Officer for The Cooper Companies, offices he held from November 2014, November 2013 and December 2011, respectively. He served as Vice President of The Cooper Companies from December 2011 to November 2013 and as its Vice President, Finance from July 2011 to December 2011. He joined CooperVision, Inc. in May 2010 as Vice President and Chief Financial Officer and served in that position until October 2011. Prior to joining CooperVision, he spent 25 years in the electronic measurement, chemical analysis and life science markets. He served in a variety of senior management roles with Agilent Technologies Inc. from 1999 to 2010, including Vice President and Controller of the Wireless Business Unit, Vice President and Director of Internal Audit and Assistant Corporate Controller. Prior to Agilent, Mr. Matz worked at Hewlett Packard from 1984 to 1999 in a variety of financial and marketing roles. Mr. Matz started his career at KPMG in San Francisco from 1981 to 1984. Mr. Matz is a Certified Public Accountant and graduated from the University of San Francisco with a B.S. in Business and the University of Pennsylvania, The Wharton School’s Advanced Management Program.

How old is Gregory Matz?

Gregory Matz is 60, he's been the Independent Director of Dare Bioscience Inc since 2018. There are 4 older and 6 younger executives at Dare Bioscience Inc. The oldest executive at Dare Bioscience Inc is William Rastetter, 72, who is the Independent Chairman of the Board.

What's Gregory Matz's mailing address?

Gregory's mailing address filed with the SEC is 2235 ENTERPRISE STREET #110, , ESCONDIDO, CA, 92029.

Insiders trading at Dare Bioscience Inc

Over the last 7 years, insiders at Dare Bioscience Inc have traded over $0 worth of Dare Bioscience Inc stock and bought 594,545 units worth $703,000 . The most active insiders traders include William H Rastetter, Roger Hawley, eCheryl R Blanchard. On average, Dare Bioscience Inc executives and independent directors trade stock every 152 days with the average trade being worth of $969,110. The most recent stock trade was executed by Roger Hawley on 11 April 2019, trading 454,545 units of DARE stock currently worth $500,000.

What does Dare Bioscience Inc do?

daré bioscience (nasdaq: dare) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s reproductive health. we are driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. we are initially focused on the areas of contraception, vaginal health and fertility. our lead product candidate, ovaprene, is a non-hormonal, monthly contraceptive ring that is currently in clinical studies.

Complete history of Mr. Matz stock trades at Cooper Companies, Dare Bioscience Inc, eOne Stop Systems Inc

Dare Bioscience Inc executives and stock owners

Dare Bioscience Inc executives and other stock owners filed with the SEC include:

• John A. Fair,
  Chief Strategy Officer
• Lisa Walters-Hoffert,
  Chief Financial Officer
• Robin Steele,
  Independent Director
• Gregory Matz,
  Independent Director
• Susan Kelley,
  Independent Director
• Steve Hall,
  Independent Director
• Jessica Grossman,
  Independent Director
• Cheryl Blanchard,
  Independent Director
• John Fair,
  Chief Business Officer
• Jame O'Neill,
  Principal Accounting Officer, Controller, Assistant Treasurer
• Lisa Walters-Hoffert,
  Chief Financial Officer
• Gregg Beloff,
  Principal Financial Officer
• Sabrina Johnson,
  President, Chief Executive Officer, Secretary, Director
• William Rastetter,
  Independent Chairman of the Board
• John Katsilometes,
  Controller
• Mary Jarosz,
  Global Head of Regulatory Affairs
• Dr. David Friend,
  Chief Scientific Officer
• MarDee J. Haring-Layton,
  VP of Accounting & Fin.
• Mark Walters,
  VP of Operations
• Roger Hawley,
  Director
• Mar Dee Haring Layton,
  Chief Accounting Officer
• Sophia Nnenna Ononye Onyia,
  Director